Profile
Dawn McCollough is the founder of Wesana Health Holdings, Inc. She is currently the President, Secretary, Treasurer & Director at Progressive Therapeutics, Inc. and the Chief Operating Officer at WeSana Health, Inc. Previously, she served as the Chairman at Lykos Therapeutics, Inc. from 2019 to 2022.
She also held positions as Head-Medical Research Operations at Biogen, Inc., Vice President-Clinical Operations at XBiotech, Inc., and Head-Global Monitoring Organization at Novartis Vaccines & Diagnostics, Inc.
Dawn McCollough active positions
| Companies | Position | Start |
|---|---|---|
WeSana Health, Inc.
 WeSana Health, Inc. Pharmaceuticals: MajorHealth Technology Part of Wesana Health Holdings, Inc., WeSana Health, Inc. engages in the development and delivery of psychedelic and naturally-sourced therapies. The company is based in Homer Glen, IL. The company was founded by Daniel Carcillo, Chad Bronstein. Daniel Carcillo has been the CEO since incorporation. WeSana Health was acquired by Debut Diamonds, Inc. on April 28, 2021. | Chief Operating Officer | - |
Progressive Therapeutics, Inc.
 Progressive Therapeutics, Inc. BiotechnologyHealth Technology Progressive Therapeutics, Inc. engages in the development of novel therapeutics. The company is based in Orleans, MA. | President | 01/04/2020 |
Former positions of Dawn McCollough
| Companies | Position | End |
|---|---|---|
Lykos Therapeutics PBC
 Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Chairman | 04/10/2022 |
| WESANA HEALTH HOLDINGS INC. | Founder | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
| XBIOTECH INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| XBIOTECH INC. | Health Technology |
| WESANA HEALTH HOLDINGS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
WeSana Health, Inc.
WeSana Health, Inc. Pharmaceuticals: MajorHealth Technology Part of Wesana Health Holdings, Inc., WeSana Health, Inc. engages in the development and delivery of psychedelic and naturally-sourced therapies. The company is based in Homer Glen, IL. The company was founded by Daniel Carcillo, Chad Bronstein. Daniel Carcillo has been the CEO since incorporation. WeSana Health was acquired by Debut Diamonds, Inc. on April 28, 2021. | Health Technology |
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Part of Multidisciplinary Association for Psychedelic Studies, Lykos Therapeutics, Inc. is a public benefit corporation that focuses on developing and commercializing prescription psychedelics to provide better treatments for people with mental health conditions. The private company is based in San Jose, CA. Lykos Therapeutics aims to catalyze healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics, prioritizing public benefit above profit. The company was founded in 2014, and the CEO is Amy Emerson. | Health Technology |
Progressive Therapeutics, Inc.
Progressive Therapeutics, Inc. BiotechnologyHealth Technology Progressive Therapeutics, Inc. engages in the development of novel therapeutics. The company is based in Orleans, MA. | Health Technology |
- Stock Market
- Insiders
- Dawn McCollough
